In This Article:
The Swedish stock market has shown resilience amidst global economic uncertainties, with insider ownership playing a crucial role in investor confidence. In this environment, companies with high insider ownership often signal strong alignment between management and shareholder interests, making them attractive for growth-oriented investors.
Top 10 Growth Companies With High Insider Ownership In Sweden
| Name | Insider Ownership | Earnings Growth |
| CTT Systems (OM:CTT) | 16.9% | 24.8% |
| Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
| Biovica International (OM:BIOVIC B) | 18.7% | 73.8% |
| Yubico (OM:YUBICO) | 37.5% | 43.8% |
| InCoax Networks (OM:INCOAX) | 18.1% | 104.9% |
| BioArctic (OM:BIOA B) | 34% | 104.2% |
| KebNi (OM:KEBNI B) | 37.8% | 90.4% |
| Calliditas Therapeutics (OM:CALTX) | 11.6% | 52.9% |
| SaveLend Group (OM:YIELD) | 23.3% | 103.4% |
| edyoutec (NGM:EDYOU) | 14.6% | 63.1% |
Let's review some notable picks from our screened stocks.
BioArctic
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB (publ) is a Swedish company that develops biological drugs for central nervous system disorders, with a market cap of SEK14.05 billion.
Operations: BioArctic AB (publ) generates revenue primarily from its biotechnology segment, amounting to SEK252.21 million.
Insider Ownership: 34%
BioArctic, a growth company with high insider ownership, has shown promising developments. Recent approvals for Leqembi in Hong Kong and South Korea highlight its potential in Alzheimer's treatment. Despite a significant drop in Q1 2024 earnings, the company's revenue is forecasted to grow at 39.1% annually, outpacing the Swedish market. Analysts agree on a potential stock price rise of 105.3%. Insiders have been buying more shares recently, indicating confidence in future performance.
-
Click to explore a detailed breakdown of our findings in BioArctic's earnings growth report.
-
Our valuation report unveils the possibility BioArctic's shares may be trading at a discount.
Pandox
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Pandox AB (publ), with a market cap of SEK37.23 billion, is a hotel property company that owns, develops, and leases hotel properties worldwide.
Operations: Pandox AB (publ) generates revenue from its Own Operation segment, which contributes SEK3.27 billion, and Rental Agreements, which bring in SEK3.82 billion.
Insider Ownership: 12.3%
Pandox AB, with substantial insider ownership, reported strong Q2 2024 earnings, showing net income of SEK 704 million compared to SEK 287 million a year ago. Revenue grew to SEK 3.37 billion for the first half of 2024. Despite lower profit margins this year (7% vs. last year's 29%), the company is expected to see annual earnings growth of over 22%, outpacing the Swedish market's average. However, its dividend sustainability and interest coverage remain concerns.